News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
181
Sources here
14
Companies here
3
Search results Stored financial headlines

Active search

181 matching headlines

Ticker or company: AMGNMain company stories
Clear
Latest

Simply Wall Street Earnings

Should Income Investors Look At Amgen Inc. (NASDAQ:AMGN) Before Its Ex-Dividend?

Amgen Inc. (NASDAQ:AMGN) is approaching its ex-dividend date, with a trailing yield of 2.4% and an upcoming dividend of US$2.52 per share. The company's dividend payouts are covered by both profit (60% payout ratio) and free cash flow (52% consumed), suggesting sustainability. While earnings per share have grown modestly at 5.5% over the last five years and dividends …

Main company 🇺🇸 United States
Read at Simply Wall Street
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
MarketBeat Analyst action Main company 🇺🇸 United States

Amgen Inc. $AMGN Shares Sold by Strive Financial Group LLC

Strive Financial Group LLC significantly reduced its stake in Amgen Inc. by 69.5% in the second quarter, selling 4,466 shares and retaining 1,957 shares valued at approximately $709,000. Despite this, Amgen reported strong quarterly earnings of $6.29 per share on $10.05 billion in revenue, …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co.

Meyer Handelman Co. decreased its stake in Amgen Inc. by 4% in the second quarter, selling 4,645 shares but still retaining 111,120 shares valued at $40.2 million. Amgen reported strong quarterly results with earnings of $6.29 per share and revenue of $10.05 billion, a …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

MarketBeat Earnings Main company 🇺🇸 United States

Todd Asset Management LLC Sells 19,948 Shares of Amgen Inc. $AMGN

Todd Asset Management LLC has reduced its stake in Amgen Inc. by 15.6%, selling 19,948 shares but still holding 108,134 shares worth approximately $39.2 million. Other institutional investors have also adjusted their positions in Amgen, which recently reported strong quarterly earnings exceeding analyst estimates …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

TD Asset Management Inc Boosts Stock Holdings in Amgen Inc. $AMGN

TD Asset Management Inc. increased its stake in Amgen Inc. by 3.9% in the second quarter, now holding 420,259 shares valued at $152.2 million. Other institutional investors like Vanguard Group and State Street Corp also significantly boosted their holdings. Despite a "Hold" consensus rating …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Commonwealth Retirement Investments LLC Decreases Stock Holdings in Amgen Inc. $AMGN

Commonwealth Retirement Investments LLC significantly reduced its stake in Amgen Inc. by 38.4% in the second quarter, selling 4,524 shares and retaining 7,243 shares valued at approximately $2.62 million. Despite this, institutional investors collectively own 76.5% of Amgen stock, and analysts have raised price …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

TCW Group Inc. Has $10.27 Million Stock Position in Amgen Inc. $AMGN

TCW Group Inc. increased its stake in Amgen Inc. by 12.8% in the second quarter, now holding 28,369 shares valued at $10.27 million. Institutional investors own 76.5% of Amgen's stock, while company insiders have recently sold shares worth over $2.5 million. Amgen reported strong …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Jennison Associates LLC Purchases 75,212 Shares of Amgen Inc. $AMGN

Jennison Associates LLC increased its stake in Amgen Inc. by 57.9% during the second quarter, acquiring an additional 75,212 shares and bringing its total holdings to 205,192 shares valued at $74.3 million. Other institutional investors also modified their positions in Amgen. The company recently …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Vontobel Holding Ltd. Acquires 4,637 Shares of Amgen Inc. $AMGN

Vontobel Holding Ltd. increased its stake in Amgen Inc. by 3.1% during the second quarter, acquiring an additional 4,637 shares to hold a total of 155,115 shares valued at $56.17 million. Other hedge funds also adjusted their positions in Amgen, with several boosting their …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Elyxium Wealth LLC Has $5.16 Million Holdings in Amgen Inc. $AMGN

Elyxium Wealth LLC significantly increased its stake in Amgen Inc. (NASDAQ:AMGN) by 607.3% in the second quarter, bringing its total holdings to $5.16 million. This move is part of a broader trend of institutional investment in Amgen, which recently reported strong quarterly earnings, raising …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
nasdaq.com Market update Main company 🇦🇷 Argentina

Dow Movers: AMGN, HONIV

In early trading on Friday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7.5%. Year to date, Honeywell International registers a 42.2% gain. And the worst performing Dow component thus far on the …

AMGN main company AMGN main company AMGN main company
Sharemaestro market context Trend signal active 52 weeks +66.3% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇺🇸 United States

Amgen (AMGN) Stock Looks Undervalued With A 37% Fair Value Gap

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Amgen stock has delivered strong gains over the past five years, yet the current …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Market update Main company 🇦🇷 Argentina

Amgen (AMGN) Opens New Science And Innovation Center In Hyderabad

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Amgen (NasdaqGS:AMGN) announced the opening of a new Science and Innovation Center in Genome Valley, Hyderabad, expanding its global research and development presence. The Hyderabad center is …

AMGN main company AMGN main company
Sharemaestro market context Trend signal active 52 weeks +66.3% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Simply Wall Street Earnings Main company 🇺🇸 United States

Amgen (AMGN) Stock Looks Below Fair Value As Caution Lingers

Amgen's stock has shown strong returns over the past five years, but recent valuation checks present a mixed picture. While a Discounted Cash Flow (DCF) analysis suggests meaningful upside, estimating an intrinsic value of $668 per share against a market price of $417.84, the …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Insider Selling: Amgen (NASDAQ:AMGN) SVP Sells $825,140.00 in Stock

Amgen SVP Rachna Khosla sold 2,000 shares of AMGN stock for $825,140 on August 11th, reducing her direct holdings by 23.8%. Two days later, she sold an additional 1,252 shares for approximately $521,370. This comes as Amgen reported strong quarterly earnings and revenue, exceeding …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

Amgen SVP Rachna Khosla sells $1.35m of stock

Rachna Khosla, Senior Vice President of Business Development at Amgen Inc. (NASDAQ:AMGN), sold approximately $1.35 million worth of company stock through two transactions in mid-August. These sales involved both direct stock sales and shares acquired through the exercise of non-qualified stock options. Following these …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
marketscreener.com Analyst action Main company 🇺🇸 United States

Daiwa Securities Adjusts Price Target on Amgen to $430 From $390, Keeps Outperform Rating

Daiwa Securities has increased its price target for Amgen (AMGN) from $390 to $430, while maintaining an "Outperform" rating on the stock. This adjustment reflects a positive outlook from the firm regarding the biotechnology group. The article also lists other recent analyst adjustments for …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
marketscreener.com Analyst action Main company 🇺🇸 United States

Barclays Adjusts Price Target on Amgen to $380 From $360, Maintains Equalweight Rating

Barclays has adjusted its price target for Amgen (AMGN) to $380, an increase from the previous $360, while maintaining an Equalweight rating on the stock. This update reflects Barclays' ongoing assessment of the biotechnology company's valuation. The article also notes recent adjustments by other …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇷 Argentina

Amgen’s Q2 Earnings Call: Our Top 5 Analyst Questions

Amgen's Q2 Earnings Call: Our Top 5 Analyst Questions Amgen's second quarter results reflected broad-based portfolio momentum, with management crediting double-digit growth in key products like Repatha, EVENITY, and TEZSPIRE for the company's outperformance versus Wall Street estimates. CEO Robert Bradway highlighted that 22 …

AMGN main company AMGN main company
Sharemaestro market context Trend signal active 52 weeks +66.3% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Simply Wall Street Earnings Main company 🇺🇸 United States

Is Amgen (AMGN) Fully Valued On Strong Q2 Results And Raised 2026 Guidance?

Amgen (AMGN) is experiencing renewed interest after strong Q2 2026 results and raised full-year guidance, leading to a significant jump in share price. While one valuation model suggests the stock is 15.6% overvalued at $416.18, another Discounted Cash Flow (DCF) model estimates it as …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Trefis Earnings Main company 🇺🇸 United States

Amgen Stock And The Price Of A Promise

Amgen recently raised its full-year revenue guidance, typically a positive signal, but its stock has not seen a significant celebratory pop. While the company's current performance is strong with multiple products showing double-digit growth, the market appears to have already factored this in. Investors …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
AD HOC NEWS Earnings Main company 🇺🇸 United States

Amgen stock trades near a yearly high after Q2 beats

Amgen's stock is trading near a yearly high after reporting strong Q2 2026 results, with EPS of $6.29 beating estimates by $0.67 and revenue reaching $10.05 billion. The company also raised its full-year EPS guidance and announced a quarterly dividend, alongside positive news regarding …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Tema ETFs LLC Increases Stock Position in Amgen Inc. $AMGN

Tema ETFs LLC significantly increased its stake in Amgen Inc. by 14.5% during the second quarter, bringing its total holdings to 26,231 shares valued at approximately $9.5 million. This move comes as Amgen reported strong Q2 earnings, beating analyst estimates with EPS of $6.29 …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

G&S Capital LLC Makes New $1.58 Million Investment in Amgen Inc. $AMGN

G&S Capital LLC has made a new $1.58 million investment in Amgen Inc. by purchasing 4,359 shares in the second quarter. The medical research company recently exceeded quarterly earnings and revenue expectations, reporting $6.29 EPS and $10.05 billion in revenue. Amgen also declared a …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
PR Newswire Balance sheet Main company 🇦🇷 Argentina

AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD

Amgen (NASDAQ: AMGN) announced its plan to open a new Science and Innovation Center in Genome Valley, Hyderabad, expanding its global R&D network. This new center aims to integrate experimental science with data and technology to accelerate the discovery and development of innovative medicines. …

AMGN main company AMGN main company AMGN main company
Sharemaestro market context Trend signal active 52 weeks +66.3% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Handelsbanken Fonder AB Has $125.51 Million Stake in Amgen Inc. $AMGN

Handelsbanken Fonder AB increased its stake in Amgen Inc. by 15.7% in the second quarter, now owning 346,596 shares valued at $125.51 million. Several other institutional investors also adjusted their positions in Amgen. The article also provides financial details, recent earnings, dividend information, and …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Amgen Inc. $AMGN Shares Acquired by KMG Fiduciary Partners LLC

KMG Fiduciary Partners LLC increased its stake in Amgen Inc. by 38.9% in the second quarter, bringing its total holdings to 9,856 shares valued at $3.57 million. Institutional investors now own 76.5% of Amgen's stock. The company recently beat earnings expectations, reporting $6.29 EPS …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Amgen (AMGN) director Charles Holley receives stock award and reports trust holdings

Amgen director Charles M. Holley reported receiving a compensation-related grant of 103.4189 shares of common stock on August 7, 2026. Following this award, he directly holds 12,990.4520 shares, which include Dividend Equivalents, and indirectly holds 1,260.0000 shares through the Holley Family Trust. This transaction …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Amgen (AMGN) director Michael V. Drake granted 63.8764 shares in equity award

Amgen director Michael V. Drake was granted 63.8764 shares of common stock as compensation on August 7, 2026. This automatic award, valued at $0.00 per share, increases his direct holdings to 5,876.1633 shares, which includes 377 Dividend Equivalents linked to unvested Restricted Stock Units. …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketWatch Market update Main company 🇺🇸 United States

Amgen Inc. stock outperforms competitors on strong trading day

Amgen Inc. stock (AMGN) rose 1.52% to $417.20 on Monday, outperforming the broader market during a challenging trading session. This marks the stock's second consecutive day of gains, contrasting with slight declines in the S&P 500 and Dow Jones Industrial Average.

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

Guggenheim raises Amgen stock price target to $388 on strong quarter

Guggenheim has increased its price target for Amgen Inc. (NASDAQ:AMGN) to $388 from $343, maintaining a Neutral rating after the company's strong second-quarter 2026 earnings. Amgen surpassed both Guggenheim's and consensus expectations, leading to revised fiscal year 2026 revenue and EPS estimates. Despite the …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
DirectorsTalk Interviews Earnings Main company 🇺🇸 United States

Amgen Inc. (AMGN) Stock Analysis: Navigating a Strong Market Cap with High Return on Equity

Amgen Inc. (AMGN) is a significant player in the healthcare sector with a market capitalization of $221.79 billion. The company boasts a strong financial position, evidenced by its forward P/E ratio of 17.03, a remarkable return on equity of 91.47%, and robust free cash …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Bitget Analyst action Main company 🇺🇸 United States

AMGEN INC : HSBC RAISES TARGET PRICE TO $445 FROM $425

HSBC has increased its target price for Amgen Inc. shares to $445, up from the previous $425. This adjustment reflects a positive outlook from the banking giant on the pharmaceutical company's stock.

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Erste Group Bank Brokers Lower Earnings Estimates for Amgen

Erste Group Bank has lowered its FY2027 EPS estimate for Amgen to $23.50 from $23.58, while maintaining a "Hold" rating on the stock. This revised estimate still remains above the current full-year consensus of $22.78. Amgen reported strong Q2 results, with EPS of $6.29 …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Market source Earnings Main company 🇺🇸 United States

Amgen Inc. (AMGN) Stock forecasts

Amgen, a leader in biotechnology, is experiencing broad-based growth despite biosimilar competition for Prolia, leading Morningstar to maintain its fair value assessment. The company's flagship drugs include Epogen, Aranesp, Neupogen, Neulasta, Enbrel, Otezla, and its first cancer therapeutic, Vectibix. The current stock price is …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Avity Investment Management Inc. Has $27.59 Million Stock Holdings in Amgen Inc. $AMGN

Avity Investment Management Inc. significantly increased its stake in Amgen Inc. by 5.3% in the second quarter, bringing its total holdings to 76,186 shares valued at approximately $27.59 million. Amgen recently reported strong second-quarter results, exceeding revenue and EPS expectations, and raised its 2026 …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context